卖什么
中药（韩药）制剂生产自动化
商业模式拆解
买家：谁掌握预算？
未核实Owner or director of a Korean-medicine clinic or pharmacy.
触发点：什么让他们现在购买？
未核实Clinics, pharmacies and wellness brands wanting precise, consistent in-house herbal/natural formulations (0.1 g dispensing, HPLC checks) without building their own GMP production.
工作流：什么输入变成什么输出？
Clinic service supports the whole clinic process: consultation, prescription, compounding/dispensing and patient management, with automated precision compounding (0.1 g units) and HPLC quality analysis.
经济账：省了什么，怎么收费？
Revenue from OEM/ODM contract manufacturing and B2B formulation, plus wholesale/retail franchise business and branding/package design services; prices not disclosed.
渠道：怎么接触到客户？
B2B direct sales to clinics plus company-branded premium pharmacies (OWNHERB Pharmacy) and a wholesale/retail franchise business; OEM/ODM inquiries via contact form.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-08-06 | A 轮 | 62억원 | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.